Medical device company AtriCure names a new president & CEO after posting its 3Q earnings, which came in below analysts' estimates.
AtriCure names Michael Carrel its new CEO
West Chester, Ohio-based device maker AtriCure (NSDQ:ATRC) named Michael Carrel as president, CEO and a member of the board of directors of the company, effective November 1.
Carrel will receive an annual base salary of $500,000, plus a $40,000 bonus and a year-end bonus of $62,500. He is also eligible for an annual performance bonus of up to 125% of his base salary, according to regulatory filings.
Carrel was previously president & CEO at Vital Images, which was acquired by Toshiba in 2011. Carrel held the role until 2012.
"Mike brings a solid track record of establishing strategic vision, expanding businesses internationally and driving revenue growth and subsequent profitability. We look forward to his leadership and contribution here at AtriCure," director Michael Hooven said during an earnings call with investors.
AtriCure also promoted Andrew Wade to principal accounting and financial officer.
VertiFlex says it won pre-market approval from the FDA for its Superion interspinous spacer.
China is investigating a former top healthcare official on suspicion of bribery.
Medtronic is reportedly looking to grow its presence in China with lower-cost devices, as well as...
Here's a look at some of the top mergers & acquisitions stories for medical device companies this...
A study of replacement heart valves treated with calcification-reducing coatings shows that the...